NADG + lidocaine

NADG + lidocaine is a combination drug comprising NADG and lidocaine. **Lidocaine** is a well-established local anesthetic of the amide type, frequently used for local and regional anesthesia by blocking sodium channels on neuronal membranes and preventing nerve impulse conduction. **NADG** does not correspond to any widely recognized pharmaceutical agent, active ingredient, or standard excipient in the literature or regulatory databases, suggesting that it may be an abbreviation, rarely used component, or a typographical anomaly. Without proper clarification of "NADG," only lidocaine's properties can be reliably described. Lidocaine's mechanism of action is to inhibit voltage-gated sodium channels, thus stabilizing neuronal membranes. The developer and main manufacturer for lidocaine include large pharmaceutical companies such as Pfizer. Lidocaine is utilized for surgical, dental, diagnostic, and obstetrical anesthesia or analgesia in both adults and pediatric patients.